- Sabesp’s net income for the fourth quarter was R$1.44 billion.
- The company’s net operating revenue for the same period reached R$7.84 billion.
- The adjusted EBITDA for Sabesp stood at R$3.00 billion with a margin of 54% in Q4.
- For the full year 2024, Sabesp reported a net income of R$9.58 billion, a significant increase from R$3.52 billion the previous year.
- Analyst recommendations for Sabesp included 15 buy ratings, 1 hold, and no sell recommendations.
A look at Cia Saneamento Basico De Sp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts using Smartkarma Smart Scores have provided insights into the long-term outlook for Cia Saneamento Basico De Sp, a company focusing on water collection, treatment, and distribution in Sao Paulo. With a strong score of 5 for Growth, it indicates a positive trajectory for the company in terms of expanding its operations and potentially increasing its market share. Additionally, a Momentum score of 4 suggests that the company has been experiencing positive momentum in its performance, which could be an indicator of further growth in the future.
Despite facing challenges in the Dividend and Resilience categories with scores of 2 and 3 respectively, the company’s overall outlook seems promising due to its strong emphasis on growth. With a Value score of 3, Cia Saneamento Basico De Sp may offer opportunities for investors looking for growth potential in the water distribution and treatment sector, despite some areas that could be improved upon.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
